While we focused on RASD2 as a target of miRNA‐485‐5p, future studies should investigate other downstream targets of miRNA‐485‐5p that may also contribute to thyroid cancer progression, providing a more complete understanding of miRNA‐485‐5p's role in this disease. The gene discussed is RASD2; the disease is thyroid gland carcinoma.